Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125856592 | 12585659 | 2 | F | 20160710 | 20160804 | 20160725 | 20160811 | EXP | US-UCBSA-2016027200 | UCB | 63.92 | YR | F | Y | 72.00000 | KG | 20160811 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125856592 | 12585659 | 1 | PS | CIMZIA | CERTOLIZUMAB PEGOL | 1 | Subcutaneous | 400 MG, EV 2 WEEKS(QOW) | Y | U | 125160 | 400 | MG | SOLUTION FOR INJECTION | QOW | ||||
| 125856592 | 12585659 | 2 | SS | CIPRO | CIPROFLOXACIN HYDROCHLORIDE | 1 | UNK | Y | U | 0 | |||||||||
| 125856592 | 12585659 | 3 | C | CELEBREX | CELECOXIB | 1 | Oral | 200 MG, 2X/DAY (BID) | U | 0 | 200 | MG | BID | ||||||
| 125856592 | 12585659 | 4 | C | FOLIC ACID. | FOLIC ACID | 1 | Oral | UNK, ONCE DAILY (QD) | U | 0 | QD | ||||||||
| 125856592 | 12585659 | 5 | C | METHOTREXATE. | METHOTREXATE | 1 | Oral | 2.5 MG, 5 TAB ONCE A WEEK | U | 0 | TABLET | ||||||||
| 125856592 | 12585659 | 6 | C | PROAIR HFA | ALBUTEROL SULFATE | 1 | UNK | U | 0 | ||||||||||
| 125856592 | 12585659 | 7 | C | ESTRADIOL. | ESTRADIOL | 1 | UNK | U | 0 | ||||||||||
| 125856592 | 12585659 | 8 | C | Multivitamins | VITAMINS | 1 | UNK | U | 0 | ||||||||||
| 125856592 | 12585659 | 9 | C | VIMOVO | ESOMEPRAZOLE MAGNESIUMNAPROXEN | 1 | UNK | U | 0 | ||||||||||
| 125856592 | 12585659 | 10 | C | VITAMIN D | CHOLECALCIFEROL | 1 | Oral | DAILY | U | 0 | |||||||||
| 125856592 | 12585659 | 11 | C | Calcium | CALCIUM | 1 | Oral | DAILY | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125856592 | 12585659 | 1 | Rheumatoid arthritis |
| 125856592 | 12585659 | 2 | Urinary tract infection |
| 125856592 | 12585659 | 3 | Rheumatoid arthritis |
| 125856592 | 12585659 | 4 | Product used for unknown indication |
| 125856592 | 12585659 | 5 | Rheumatoid arthritis |
| 125856592 | 12585659 | 6 | Product used for unknown indication |
| 125856592 | 12585659 | 7 | Product used for unknown indication |
| 125856592 | 12585659 | 8 | Product used for unknown indication |
| 125856592 | 12585659 | 9 | Product used for unknown indication |
| 125856592 | 12585659 | 10 | Supplementation therapy |
| 125856592 | 12585659 | 11 | Supplementation therapy |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125856592 | 12585659 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125856592 | 12585659 | Abdominal discomfort | |
| 125856592 | 12585659 | Urinary tract infection |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125856592 | 12585659 | 1 | 20160616 | 20160714 | 0 | |
| 125856592 | 12585659 | 2 | 20160711 | 20160711 | 0 |